Carregant...

The place of intravenous immunoglobulin in rheumatic diseases

Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: N. V. Seredavkina, T. M. Reshetnyak, E. L. Nasonov
Format: Artigo
Idioma:Russo
Publicat: IMA-PRESS LLC 2016-01-01
Col·lecció:Современная ревматология
Matèries:
Accés en línia:https://mrj.ima-press.net/mrj/article/view/655
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!